Can a simple DNA test predict esophageal cancer before it starts?
NCT ID NCT00431756
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study aims to find early DNA changes in blood and esophageal tissue that could signal a higher risk of developing esophageal cancer. Researchers are studying 600 people with gastroesophageal reflux, Barrett's esophagus, or esophageal cancer who are already scheduled for an upper endoscopy. By identifying these early markers, doctors may one day be able to predict and monitor cancer progression more effectively.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BARRETT ESOPHAGUS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Johns Hopkins Hospital
Baltimore, Maryland, 21287, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a swallowed balloon unlock the genetic secrets of esophageal cancer?
- Pulsing radiation may spare esophageal cancer patients from agonizing throat pain
- Zapping the esophagus: an implantable device takes on chronic heartburn
- Personalized radiation pulses could boost esophageal cancer treatment
- Light-Activated therapy shows promise for tumor control without surgery
- Could a dye and camera spare esophageal cancer patients from extensive lymph node removal?